Bifogade filer
Prenumeration
Beskrivning
Land | Sverige |
---|---|
Lista | Nordic SME Sweden |
Sektor | Hälsovård |
Industri | Medicinteknik |
Today, November 12, 2024, is the last day of trading with the warrants of series TO6 in Lumito AB (publ) (“Lumito” or the “Company”). The exercise period for the warrants runs up to and including November 15, 2024. Each warrant of series TO6 gives the owner the right to subscribe for one (1) new share in the Company for a subscription price of SEK 0.39 per share.
Summarized terms for the warrants of series TO6:
Exercise period: November 4, 2024 – November 15, 2024.
Subscription price: SEK 0.39 per share.
Issue volume: 34,406,248 warrants of series TO6 entitles to subscription of 34,406,248 shares. If all warrants are exercised the Company will receive approximately SEK 13.4 million before issuing costs.
Last day for trading with warrants: November 12, 2024.
Share capital and dilution: If all warrants of series TO6 are exercised the number of shares will increase with 34,406,248 shares from 233,691,423 shares to 268,097,671 shares and the share capital will increase with SEK 860,156.20, from SEK 5,842,285.58 to SEK 6,702,441.78, corresponding to a maximal dilution effect of 12.8 percent if the number of shares.
Note that the warrants that are not exercised at the latest November 15, 2024, or sold at the latest November 12, 2024, will expire without value. For the warrants of series TO6 not to lose their value, the holder must actively subscribe for new shares or sell the warrants. Please note that some nominees may close registration earlier than November 15, 2024.
Advisers
Mangold Fondkommission AB is financial adviser and Advokatfirman Lindahl KB is legal advisor to Lumito in connection with the exercise of the warrants of series TO6.